A novel glycosylated indolocarbazole derivative LCS1269 effectively inhibits growth of human cancer cells in vitro and in vivo through driving of both apoptosis and senescence by inducing of DNA damage and modulating of AKT/mTOR/S6K and ERK pathways

DSpace Repositorium (Manakin basiert)

A novel glycosylated indolocarbazole derivative LCS1269 effectively inhibits growth of human cancer cells in vitro and in vivo through driving of both apoptosis and senescence by inducing of DNA damage and modulating of AKT/mTOR/S6K and ERK pathways

Autor(en): Kalitin, Nikolay N.; Ektova, Lidia V.; Kostritsa, Natalia S.; Sivirinova, Anastasia S.; Kostarev, Alexander V.; Smirnova, Galina B.; Borisova, Yulia A.; Golubeva, Irina S.; Ermolaeva, Elisaveta V.; Vergun, Maria A.; Babaeva, Maria A.; Lushnikova, Anna A.; Karamysheva, Aida F.
Tübinger Autor(en):
Kostarev, Alexander V.
Erschienen in: Chemico - Biological Interactions (2022), Bd. 364, Article 110056
Verlagsangabe: Elsevier Ireland Ltd
Sprache: Englisch
Referenz zum Volltext: http://dx.doi.org/10.1016/j.cbi.2022.110056
ISSN: 0009-2797
DDC-Klassifikation: 570 - Biowissenschaften, Biologie
610 - Medizin, Gesundheit
Dokumentart: Wissenschaftlicher Artikel
Zur Langanzeige

Das Dokument erscheint in: